Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Brian G, Hartl"'
Autor:
Wayne Klohs, Denise L. Driscoll, Aneesa M. Amar, Wilbur R. Leopold, H. D. Hollis Showalter, Brian G. Hartl, William L. Elliott, Bill J. Roberts, Stacey L. Boushelle, Andrew M. Thompson, Randall W. Steinkampf, Connolly Cleo, Patrick W. Vincent, William A. Denny, James M. Hamby, Sandra J. Patmore, Alan J. Kraker
Publikováno v:
Journal of Medicinal Chemistry. 43:4200-4211
A series of 3-aryl-1,6-naphthyridine-2,7-diamines and related 2-ureas were prepared and evaluated as inhibitors of the FGF receptor-1 tyrosine kinase. Condensation of 4,6-diaminonicotinaldehyde and substituted phenylacetonitriles gave intermediate na
Autor:
Alan J. Kraker, Charles W. Moore, Barvian Mark Robert, Brian G. Hartl, H. D. Hollis Showalter, Aneesa Amar
Publikováno v:
Biochemical Pharmacology. 60:885-898
Increased expression or activity of c-Src tyrosine kinase has been associated with the transformed phenotype in tumor cells and with progression of neoplastic disease. A number of pyrido[2, 3-d]pyrimidines have been characterized biochemically and in
Autor:
Brian G. Hartl, Randy Steinkampf, T C Major, Joan A. Keiser, Tawny K. Dahring, H. D. Hollis Showalter, Gina H. Lu, Alan J. Kraker, Robert L. Panek, Hussein Hallak, Brian L. Batley, Zhipei Wu, Bill J. Roberts, Sylvester Klutchko, Sandra J. Patmore, William L. Elliott, Laura A. Bradford, Wayne D. Klohs, Annette Marian Doherty, James Marino Hamby, Diane H. Boschelli
Publikováno v:
Journal of Medicinal Chemistry. 41:4365-4377
Screening of a compound library led to the identification of 2-amino-6-(2,6-dichlorophenyl)-8-methylpyrido[2,3-d]pyrimidine (1) as a inhibitor of the platelet-derived growth factor receptor (PDGFr), fibroblast growth factor receptor (FGFr), and c-src
Autor:
Aneesa Amar, Gina H. Lu, Alan J. Kraker, H. D. Hollis Showalter, James Marino Hamby, Barvian Mark Robert, Brian G. Hartl, Robert L. Panek
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:2903-2908
Fibroblast growth factor receptor (FGFr) mediated signal transduction is implicated in vascular proliferative diseases and some cancers. We have identified methyl 1-oxo-3-phenyl-1H-indene-2-carboxylic ester as a small molecule inhibitor of the tyrosi
Autor:
Alan J. Kraker, Brian G. Hartl, Gina H. Lu, James Marino Hamby, H. D. Hollis Showalter, Aneesa Amar, Robert L. Panek, Barvian Mark Robert
Publikováno v:
ChemInform. 29
Fibroblast growth factor receptor (FGFr) mediated signal transduction is implicated in vascular proliferative diseases and some cancers. We have identified methyl 1-oxo-3-phenyl-1H-indene-2-carboxylic ester as a small molecule inhibitor of the tyrosi
Autor:
Alan J, Kraker, Craig A, Mizzen, Brian G, Hartl, Johnson, Miin, C David, Allis, Ronald L, Merriman
Publikováno v:
Molecular cancer therapeutics. 2(4)
CI-994 or N-acetyldinaline [4-(acetylamino)-N-(2-amino-phenyl) benzamide] is an antitumor cytostatic agent currently undergoing clinical trial. Although several changes in cellular metabolism induced by the drug have been characterized, the primary m
Autor:
William A. Denny, Robert L. Panek, Brian L. Batley, Andrew M. Thompson, Stacey L. Boushelle, Gina H. Lu, H. D. Hollis Showalter, Gordon W. Rewcastle, Brian G. Hartl, Alan J. Kraker
Publikováno v:
Journal of medicinal chemistry. 43(16)
7-substituted 3-(2,6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones are potent inhibitors of protein tyrosine kinases, with some selectivity for c-Src. The compounds were prepared by condensing 4, 6-diaminonicotinaldehyde with 2,6-dichlorophenylacetonit
Autor:
Alan J. Kraker, William A. Denny, Brian D. Palmer, Robert L. Panek, Brian G. Hartl, Gina H. Lu, H. D. Hollis Showalter, Susanne Trumpp-Kallmeyer, Athanasia D. Panopoulos, Brian L. Batley
Publikováno v:
Journal of medicinal chemistry. 42(13)
Following an earlier discovery of 1-phenylbenzimidazoles as ATP-site inhibitors of the platelet-derived growth factor receptor (PDGFR), further structure-activity relationships for analogues (particularly 5-substituted derivatives) are reported. The
Autor:
Patrick W. Vincent, Aneesa M. Amar, Gina H. Lu, Diane H. Boschelli, James M. Nelson, Hussein Hallak, Sylvester Klutchko, Donald J. Dykes, Laura A. Bradford, Panek Rl, Chad L. Stoner, Wayne D. Klohs, James M. Hamby, Brian G. Hartl, H. D. Hollis Showalter, Randall W. Steinkampf, Alan J. Kraker, Annette M. Doherty, Billy J. Roberts, Cynthia Shen, William L. Elliott, Terry C. Major, Tawny K. Dahring, Zhipei Wu, Denise L. Driscoll
Publikováno v:
Journal of medicinal chemistry. 41(17)
While engaged in therapeutic intervention against a number of proliferative diseases, we have discovered the 2-aminopyrido[2, 3-d]pyrimidin-7(8H)-ones as a novel class of potent, broadly active tyrosine kinase (TK) inhibitors. An efficient route was